8-KLeadership ChangesRegulation FDExhibits & Filings

Elevance Health, Inc. 8-K Report, Executive Changes (May 26, 2015)

Filed May 26, 2015For Securities:ELV

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on May 26, 2015, primarily reporting on two key events. Firstly, it announced the impending retirement of Kenneth R. Goulet, Executive Vice President and President of Commercial and Specialty Business, expected later in the summer of 2015. Mr. Goulet's departure is for personal reasons and not due to any disagreements with the company, with arrangements being made for a smooth transition of his responsibilities. Secondly, the company reaffirmed its full-year 2015 net income guidance. Elevance Health anticipates its net income to be greater than $9.47 per share, which includes approximately $0.43 per share in net unfavorable items. Excluding these specific items, the adjusted net income guidance is projected to be greater than $9.90 per share. This reiteration indicates no new unfavorable adjustments beyond those previously disclosed in the first quarter of 2015.

Key Highlights

  • 1Announcement of the retirement of Kenneth R. Goulet, EVP and President of Commercial and Specialty Business, expected in summer 2015.
  • 2Mr. Goulet's retirement is for personal reasons and not due to any company disputes, ensuring a planned transition.
  • 3Elevance Health (then Anthem, Inc.) reaffirmed its full-year 2015 net income guidance.
  • 4The company expects full-year 2015 net income to exceed $9.47 per share.
  • 5This guidance includes an anticipated $0.43 per share in net unfavorable items.
  • 6Adjusted net income guidance for full-year 2015 is projected to be greater than $9.90 per share.
  • 7No new net adjustment items beyond those reported in Q1 2015 have been included in the reaffirmed guidance.

Frequently Asked Questions

Kenneth R. Goulet was the Executive Vice President and President of the Commercial and Specialty Business at Elevance Health (then Anthem, Inc.). He announced his intention to retire later in the summer of 2015.

Mr. Goulet's retirement is stated to be for personal reasons and not due to any disagreement or dispute with the company. This suggests a planned and amicable departure.

Elevance Health reaffirmed its full-year 2015 net income guidance, expecting it to be greater than $9.47 per share. This includes an anticipated $0.43 per share of net unfavorable items, leading to an adjusted net income guidance of greater than $9.90 per share.

No, the reaffirmed guidance explicitly states that it includes no additional net adjustment items beyond those already reported in the company's first quarter 2015 earnings release.